364 related articles for article (PubMed ID: 26700245)
1. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1.
Yu R; Zheng L; Cui Y; Zhang H; Ye H
Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245
[TBL] [Abstract][Full Text] [Related]
2. The allosteric modulation effects of doxycycline, minocycline, and their derivatives on the neuropeptide receptor PAC1-R.
Song S; Wang L; Li J; Huang X; Yu R
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):627-637. PubMed ID: 31056648
[TBL] [Abstract][Full Text] [Related]
3. Novel peptide VIP-TAT with higher affinity for PAC1 inhibited scopolamine induced amnesia.
Yu R; Yang Y; Cui Z; Zheng L; Zeng Z; Zhang H
Peptides; 2014 Oct; 60():41-50. PubMed ID: 25086267
[TBL] [Abstract][Full Text] [Related]
4. Dimer-dependent intrinsic/basal activity of the class B G protein-coupled receptor PAC1 promotes cellular anti-apoptotic activity through Wnt/β-catenin pathways that are associated with dimer endocytosis.
Yu R; Cui Z; Li M; Yang Y; Zhong J
PLoS One; 2014; 9(11):e113913. PubMed ID: 25426938
[TBL] [Abstract][Full Text] [Related]
5. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
6. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
Apostolakis EM; Riherd DN; O'Malley BW
Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
[TBL] [Abstract][Full Text] [Related]
7. TAT-tagging of VIP exerts positive allosteric modulation of the PAC1 receptor and enhances VIP neuroprotective effect in the MPTP mouse model of Parkinson's disease.
Yu R; Li J; Lin Z; Ouyang Z; Huang X; Reglodi D; Vaudry D
Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129626. PubMed ID: 32335135
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
9. Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.
Dejda A; Bourgault S; Doan ND; Létourneau M; Couvineau A; Vaudry H; Vaudry D; Fournier A
Biochimie; 2011 Apr; 93(4):669-77. PubMed ID: 21185349
[TBL] [Abstract][Full Text] [Related]
10. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
11. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.
Bourgault S; Vaudry D; Ségalas-Milazzo I; Guilhaudis L; Couvineau A; Laburthe M; Vaudry H; Fournier A
J Med Chem; 2009 May; 52(10):3308-16. PubMed ID: 19413310
[TBL] [Abstract][Full Text] [Related]
12. PACAP induces the dimerization of PAC1 on the nucleus associated with the cAMP increase in the nucleus.
Yu R; Zhong J; Li M; Guo X; Zhang H; Chen J
Neurosci Lett; 2013 Aug; 549():92-6. PubMed ID: 23792266
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.
Abu-Hamdan MD; Drescher MJ; Ramakrishnan NA; Khan KM; Toma VS; Hatfield JS; Drescher DG
Neuroscience; 2006 Jun; 140(1):147-61. PubMed ID: 16626868
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
16. The functional recombinant first extracellular (EC1) domain of PACAP receptor PAC1 normal form (PAC1-EC1(N)) recognizes selective ligands and stimulates the proliferation of PAC1-CHO cells.
Yu R; Li J; Wang J; Liu X; Huang L; Ding Y; Chen J
Neurosci Lett; 2010 Aug; 480(1):73-7. PubMed ID: 20553998
[TBL] [Abstract][Full Text] [Related]
17. PACAP and PAC1 receptor in brain development and behavior.
Shen S; Gehlert DR; Collier DA
Neuropeptides; 2013 Dec; 47(6):421-30. PubMed ID: 24220567
[TBL] [Abstract][Full Text] [Related]
18. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
[TBL] [Abstract][Full Text] [Related]
19. Hormesis effect of hydrogen peroxide on the promoter activity of neuropeptide receptor PAC1-R.
Huang X; Li J; Song S; Wang L; Lin Z; Ouyang Z; Yu R
J Food Biochem; 2019 Jul; 43(7):e12877. PubMed ID: 31353704
[TBL] [Abstract][Full Text] [Related]
20. Novel Small Molecule Positive Allosteric Modulator SPAM1 Triggers the Nuclear Translocation of PAC1-R to Exert Neuroprotective Effects through Neuron-Restrictive Silencer Factor.
Fan G; Chen S; Liang L; Zhang H; Yu R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
